Evaluating single-institution resource costs of consolidative radiotherapy for oligometastatic non-small cell lung cancer using time-driven activity-based costing

BACKGROUND: Consolidative radiotherapy (RT) has been shown to improve overall survival in oligometastatic non-small cell lung cancer (NSCLC), as demonstrated by a growing number of prospective trials. OBJECTIVE: We quantified the costs of delivery of consolidative RT for common clinical pathways ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Pezzi, Todd A., Ning, Matthew S., Thaker, Nikhil G., Boyce-Fappiano, David, Gjyshi, Olsi, Olivieri, Nicholas D., Guzman, Alexis B., Incalcaterra, James R., Mesko, Shane, Gandhi, Saumil, Chun, Stephen, Tang, Chad, Frank, Steven J., Gomez, Daniel R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283089/
https://www.ncbi.nlm.nih.gov/pubmed/32529054
http://dx.doi.org/10.1016/j.ctro.2020.05.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283089/
https://www.ncbi.nlm.nih.gov/pubmed/32529054
http://dx.doi.org/10.1016/j.ctro.2020.05.007

Ejemplares similares